Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)
NCT01155427 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2010-07-01
Summary
The purpose of this study is to support the clinical value of entecavir by assessing the relationship between viral load and histological improvement.
Conditions
- Hepatitis B, Chronic
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-31
- Primary Completion
- 2010-04-30
- Completion
- 2010-04-30
More Related Trials
-
Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials
NCT01438424 ·Status: COMPLETED ·Phase: PHASE2
-
Antiviral Therapy for Patients With Chronic Hepatitis B Infection
NCT05382351 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B Infection
NCT01020565 ·Status: COMPLETED ·Phase: PHASE2
-
Continue Entecavir Rollover From China
NCT00975091 ·Status: COMPLETED ·Phase: PHASE3
-
Stopping Antiviral Treatment in Chronic Hepatitis B
NCT04431245 ·Status: ACTIVE_NOT_RECRUITING
-
An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection
NCT01037062 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
NCT00423891 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation
NCT00065507 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection
NCT00096785 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials
NCT01337479 ·Status: COMPLETED
-
Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B
NCT02075294 ·Status: COMPLETED
-
Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load
NCT01013272 ·Status: COMPLETED ·Phase: NA
-
Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
NCT01341743 ·Status: UNKNOWN ·Phase: PHASE4
-
Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis
NCT04160897 ·Status: UNKNOWN
-
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen
NCT00035633 ·Status: COMPLETED ·Phase: PHASE3
-
Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria
NCT04264312 ·Status: COMPLETED
-
Suboptimal Responders to Adefovir Switching to Entecavir
NCT00718887 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen
NCT00035789 ·Status: COMPLETED ·Phase: PHASE3
-
Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT
NCT01833611 ·Status: UNKNOWN ·Phase: PHASE4
-
Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy
NCT01037166 ·Status: COMPLETED ·Phase: PHASE2
-
Prophylaxis of Hepatitis B Virus Recurrence After Liver Transplantation
NCT01139203 ·Status: UNKNOWN ·Phase: NA
-
Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program
NCT00096811 ·Status: NO_LONGER_AVAILABLE
-
The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Trial
NCT03509688 ·Status: COMPLETED ·Phase: NA
-
Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
NCT01829685 ·Status: UNKNOWN ·Phase: PHASE4
-
Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B
NCT00410072 ·Status: COMPLETED ·Phase: PHASE3